Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28423598 | 0.85 | CA1 (0.40) | CA1CA2CA12CA7CA14 | |
| SCHEMBL6113276 | 0.82 | TSHR (0.39) | CA1CA2CA12CA7CA14 | |
| SCHEMBL28160424 | 0.79 | CA1 (0.48) | CA1CA2CA12CA7CA14 | |
| SCHEMBL11760074 | 0.77 | TSHR (0.39) | CA1CA2CA12CA7CA14 | |
| SCHEMBL2233250 | 0.77 | TSHR (0.42) | CA1CA2CA12CA7CA14 | |
| SCHEMBL17319467 | 0.77 | TSHR (0.42) | CA1CA2CA12CA7CA14 | |
| SCHEMBL8396145 | 0.77 | CA1 (0.42) | CA1CA2CA9 | |
| SCHEMBL11350925 | 0.74 | TSHR (0.43) | CA1CA2CA12CA7CA14 | |
| SCHEMBL28160471 | 0.74 | CA1 (0.41) | CA1CA2 | |
| SCHEMBL2461932 | 0.73 | CA1 (0.39) | CA1CA2TSHRTP53CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11036132-B2 | Resist composition, method of forming resist pattern, compound, and acid diffusion control agent | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-06-15 | — | — | US | disclosed |
| US-20190204735-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, COMPOUND, AND ACID DIFFUSION CONTROL AGENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11036132-B2 | Resist composition, method of forming resist pattern, compound, and acid diffusion control agent | RB1, RBBP5, RBBP4 | CA1 529/4885CA2 416/4885CA12 312/4885 |
| US-20190204735-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, COMPOUND, AND ACID DIFFUSION CONTROL AGENT | RB1, RBBP5, RBBP4 | CA1 529/4885CA2 416/4885CA12 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.